Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
During the quarter ended June 30, 2025, the Meridian Growth Fund returned 4.10% (net), underperforming its benchmark, the Russell 2500 Growth Index, which posted a robust 11.31% return. U.S. equity markets...
— ArrowMark Colorado Holdings, LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Halozyme Therapeutics
No other institutional pitches found for this ticker yet.